The Biologics News and Reports Portal

Show Cart

Target Pipelines

Results 1 - 10 of 67

May 2022 Cadherin 17: A target opportunity to develop effector-enhanced drug modalities

400.00 €

May 2022 Claudin 6: A target opportunity to develop effector-enhanced drug modalities

500.00 €

Dec 2018 Interleukin-33/Receptor Targeted Antibodies – Target Pipeline List 12/2018

75.00 €

Nov 2018 Neulasta Biosimilars – Target Pipeline List 11/2018

150.00 €

Nov 2018 Avastin Biosimilars - Target Pipeline List 11/2018

150.00 €

Nov 2018 MerTK Inhibitors – Target Pipeline List 11/2018

100.00 €

Nov 2018 Humira Biosimilars – Target Pipeline List 11/2018

150.00 €

Start
Prev
1
2
3
4
5
6
7
Next
End

Shopping cart

Cart empty

Latest report

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

Featured Products

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Masked Antibodies & Cytokines As Prodrugs:a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective

Latest Target Pipeline

Cadherin 17: A target opportunity to develop effector-enhanced drug modalities

Shopping cart

Cart empty

Latest report

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

Featured Products

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Masked Antibodies & Cytokines As Prodrugs:a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective

Target Pipelines

May 2022 Cadherin 17: A target opportunity to develop effector-enhanced drug modalities

May 2022 Claudin 6: A target opportunity to develop effector-enhanced drug modalities

Apr 2020 STING Agonists & Antagonists – Target Pipeline List 04/2020

Feb 2020 TIGIT-Targeted Immunotherapeutics – Target Pipeline List 02/2020

Dec 2018 TFPI Inhibitors – Target Pipeline List

Dec 2018 Interleukin-33/Receptor Targeted Antibodies – Target Pipeline List 12/2018

Nov 2018 Neulasta Biosimilars – Target Pipeline List 11/2018

Nov 2018 Avastin Biosimilars - Target Pipeline List 11/2018

Nov 2018 MerTK Inhibitors – Target Pipeline List 11/2018

Nov 2018 Humira Biosimilars – Target Pipeline List 11/2018

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing